+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatocellular Carcinoma Drug"

Hepatocellular Carcinoma Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Global Unresectable Hepatocellular Carcinoma Market by Systemic Treatment (Chemotherapy, Immunotherapy, Molecularly Targeted Therapy), End User (Cancer Centers, Hospitals, Research institutes) - Forecast 2024-2030 - Product Thumbnail Image

Global Unresectable Hepatocellular Carcinoma Market by Systemic Treatment (Chemotherapy, Immunotherapy, Molecularly Targeted Therapy), End User (Cancer Centers, Hospitals, Research institutes) - Forecast 2024-2030

  • Report
  • March 2024
  • 197 Pages
  • Global
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Global Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032

  • Report
  • September 2022
  • 247 Pages
  • Global
From
Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis, and Competitive Landscape - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

Natural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis, and Competitive Landscape - Analysis and Forecast, 2022-2032

  • Report
  • June 2022
  • 207 Pages
  • Global
From
Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • January 2023
  • 189 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hepatocellular Carcinoma - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatocellular Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatocellular Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global CAR T Cell Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
  • February 2018
  • Global
From
Global Hepatocellular Carcinoma Treatment Market 2021-2025 - Product Thumbnail Image

Global Hepatocellular Carcinoma Treatment Market 2021-2025

  • Report
  • February 2021
  • 120 Pages
  • Global
From
Hepatocellular Carcinoma: Competitive Landscape to 2026 - Product Thumbnail Image

Hepatocellular Carcinoma: Competitive Landscape to 2026

  • Report
  • November 2018
  • 50 Pages
  • Global
From
Cancer Testis Antigen 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Cancer Testis Antigen 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 76 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 1275 Pages
  • Global
From
Hepatocellular Carcinoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Hepatocellular Carcinoma Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • June 2023
  • 111 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 109 Pages
  • Global
From
Loading Indicator

The Hepatocellular Carcinoma Drug market is a subset of the Oncology Drugs market. It is composed of drugs used to treat hepatocellular carcinoma (HCC), a type of liver cancer. These drugs are used to reduce the size of tumors, slow the growth of cancer cells, and reduce symptoms. Commonly used drugs include sorafenib, lenvatinib, and regorafenib. Other treatments, such as chemotherapy, radiation therapy, and surgery, may also be used in combination with these drugs. The Hepatocellular Carcinoma Drug market is highly competitive, with many companies offering treatments for HCC. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies, such as AbbVie, AstraZeneca, and Eli Lilly, also offer treatments for HCC. Show Less Read more